| Literature DB >> 31315625 |
Charlène Mauger1, Kathleen Gilbert1,2, Aaron M Lee3, Mihir M Sanghvi3, Nay Aung3, Kenneth Fung3, Valentina Carapella4, Stefan K Piechnik4, Stefan Neubauer4, Steffen E Petersen3, Avan Suinesiaputra1, Alistair A Young5,6.
Abstract
BACKGROUND: The associations between cardiovascular disease (CVD) risk factors and the biventricular geometry of the right ventricle (RV) and left ventricle (LV) have been difficult to assess, due to subtle and complex shape changes. We sought to quantify reference RV morphology as well as biventricular variations associated with common cardiovascular risk factors.Entities:
Keywords: Atlases; Cardiovascular magnetic resonance; UK biobank; Ventricular function
Mesh:
Year: 2019 PMID: 31315625 PMCID: PMC6637624 DOI: 10.1186/s12968-019-0551-6
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Characteristics of the participants included in the atlas, and the reference healthy sub-cohort. The data are presented as mean ± std. dev. or number of positives (% of total). MI, myocardial infarction
| Total | Reference healthy sub-cohort | |
|---|---|---|
| n | 4329 | 630 |
| Age (years) | 62.0 ± 7.5 | 59.1 ± 6.3 |
| Male | 2057 (48%) | 290 (46%) |
| Weight (kg) | 75.8 ± 15.3 | 69.2 ± 11.7 |
| Height (cm) | 169.8 ± 9.4 | 169.9 ± 8.1 |
| Smoking | 280 (6%) | 0 |
| High cholesterol | 294 (7%) | 0 |
| Previous MI | 93 (2%) | 0 |
| Diabetes | 223 (5%) | 0 |
| Angina | 101 (2%) | 0 |
| High blood pressure | 1125 (26%) | 0 |
| Obesity | 709 (16%) | 0 |
Fig. 1Biventricular coarse mesh (left) and its Catmull Clark subdivision at level 2 (right). The left ventricle (LV) is shown in green, the right ventricle (RV) in blue and the epicardium in red. The mitral valve is highlighted in cyan, the aortic valve in yellow, the tricuspid valve in magenta and the pulmonary valve in green
Fig. 2Atlas construction pipeline: a 3D contour points extracted from 2D contour points. Mitral points are shown in blue and tricuspid points in red. b Registration framework. c Registration results. d Principal component analysis of shape variation. Upper and lower panel show ±2 std. dev in the fourth mode at end-diastole (ED)
Fig. 3Bland-Altman agreement plots between biventricular mesh fitting and manual analysis. a LV end-diastolic volume index, b LV end-systolic index, c RV end-diastolic index, and d RV end-systolic index. Mean biases and ± 2 std. dev of measurement differences are shown as horizontal dashed lines. LV = left ventricle. RV = right ventricle
Fig. 4First four components of variation for the combined end-diastole (ED) and end-systole (ES) atlas. The ED is shown in wireframe and the ES in solid mesh. The right ventricle is shown in blue, the LV in green and the LV epicardium in red. The mitral valve is shown in pink and the tricuspid valve in yellow. The red arrow shows changes in the motion of the tricuspid valve. The left and right shapes of each mode correspond to the mean ± 2 std. dev. Animations of these shape components have been provided in the Additional file 1: Figure S2
Fig. 5Percentage of variance explained as a function of mode for the atlas
Ten-fold cross-validation results from penalized logistic regression models using the first 50 PCA modes (PCA50) and from the reference baseline mass/volumes (MassVol) measurement models
| Factor | Model | AUC | Sensitivity | Specificity | Precision | F1-score | npv | Cutoff |
|---|---|---|---|---|---|---|---|---|
| Cholesterol | MassVol | 0.587 | 0.704 | 0.451 | 0.346 | 0.464 | 0.787 | 0.495 |
| PCA50* | 0.751 | 0.792 | 0.579 | 0.437 | 0.564 | 0.871 | 0.485 | |
| Smoking | MassVol | 0.594 | 0.856 | 0.287 | 0.334 | 0.480 | 0.826 | 0.490 |
| PCA50* | 0.699 | 0.525 | 0.795 | 0.517 | 0.521 | 0.800 | 0.511 | |
| Diabetes | MassVol | 0.652 | 0.740 | 0.554 | 0.342 | 0.468 | 0.872 | 0.494 |
| PCA50* | 0.817 | 0.704 | 0.781 | 0.502 | 0.586 | 0.894 | 0.504 | |
| Previous MI | MassVol | 0.733 | 0.699 | 0.663 | 0.235 | 0.351 | 0.937 | 0.490 |
| PCA50* | 0.853 | 0.677 | 0.911 | 0.529 | 0.594 | 0.950 | 0.518 | |
| Angina | MassVol | 0.671 | 0.700 | 0.637 | 0.196 | 0.307 | 0.944 | 0.497 |
| PCA50* | 0.773 | 0.663 | 0.763 | 0.262 | 0.376 | 0.947 | 0.493 | |
| Obesity | MassVol | 0.682 | 0.675 | 0.598 | 0.638 | 0.656 | 0.637 | 0.494 |
| PCA50* | 0.839 | 0.760 | 0.763 | 0.771 | 0.766 | 0.752 | 0.500 | |
| Hypertension | MassVol | 0.651 | 0.693 | 0.543 | 0.718 | 0.705 | 0.514 | 0.495 |
| PCA50* | 0.770 | 0.752 | 0.663 | 0.789 | 0.770 | 0.615 | 0.494 |
Statistical tests were performed between MassVol and PCA50. Significant differences (p < 0.005) are represented with an asterisk
PCA principal component analysis, MI myocardial infarction
Fig. 6Receiver Operating Characteristics (ROC) curves and Precision-Recall curves for each risk factor regression model. MassVol and PCA50 models are shown by red and blue curves, respectively
Fig. 7Shape changes due to high blood pressure (a) and smoking (b), adjusted for age, sex, height and other factors. Colors denote difference from the mean shape in mm (red outward, blue inward) for factor positive (Positive) and factor negative (Negative) groups. Outward directions are shown on the top right picture. Top row: anterior view of the RV (left) and LV (right). Bottom row: posterior view (left: LV, right: RV). Histograms show morphometric scores for reference healthy group and factor positive group
Volume and dimension differences (%) between the positive and negative means generated from each of the linear regression morphometric modes
| Smoking | Chol | Previous MI | Diabetes | Angina | HBP | Obesity | |
|---|---|---|---|---|---|---|---|
| RV EDV | −3.1 | −1.5 | 4.2 | −3.4 | 0.7 | −0.1 | 8.5 |
| RV ESV | −1.7 | −2.1 | 4.3 | −2.6 | −1.1 | −2.4 | 10.1 |
| RV Eccen. | 0.514 | −0.77 | 3.91 | −0.58 | − 0.38 | − 0.89 | − 0.72 |
| RV Spher. | − 0.08 | 1.2 | 0.04 | − 0.24 | 0.77 | −0.33 | 1.21 |
| RV Short. | −1.74 | − 1.8 | 2.19 | −0.02 | 1.85 | 1.84 | −1.36 |
| LV EDV | −1.7 | −2.2 | 11.7 | −3.3 | 1.6 | 1.4 | 7.3 |
| LV ESV | 0.6 | −4.2 | 18.4 | −2.5 | 0.8 | 1.0 | 7.8 |
| LV Mass | −0.5 | −3.1 | 5.4 | −1.3 | 1.7 | 5.1 | 13.9 |
| LV MVR | 1.2 | −0.8 | −7.1 | 1.9 | 0.1 | 3.7 | 7.1 |
| LV RWT | 1.1 | −0.7 | −5.8 | 1.2 | 0.1 | 3.1 | 6.4 |
| LV Eccen. | −0.07 | 0.2 | 0.02 | 0.6 | 0.1 | 0.9 | 1.4 |
| LV Spher. | −0.2 | −0.2 | 8.4 | 0.1 | 1.0 | −1 | 2.1 |
| LV Short. | −0.9 | 0.8 | −3.6 | 0.2 | 1.8 | 0.8 | −0.1 |
EDV end-diastolic volume, ESV end-systolic volume, Eccen. eccentricity, Spher. sphericity, Short longitudinal shortening, LV MVR left ventricular mass to volume ratio, LV RWT left ventricular relative wall thickness